GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » RTW Biotech Opportunities Ltd (LSE:RTW) » Definitions » Beta

RTW Biotech Opportunities (LSE:RTW) Beta : -0.42 (As of Dec. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is RTW Biotech Opportunities Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-12-13), RTW Biotech Opportunities's Beta is -0.42.


RTW Biotech Opportunities Beta Historical Data

The historical data trend for RTW Biotech Opportunities's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RTW Biotech Opportunities Beta Chart

RTW Biotech Opportunities Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial - - - - -0.27

RTW Biotech Opportunities Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -0.27

Competitive Comparison of RTW Biotech Opportunities's Beta

For the Asset Management subindustry, RTW Biotech Opportunities's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RTW Biotech Opportunities's Beta Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, RTW Biotech Opportunities's Beta distribution charts can be found below:

* The bar in red indicates where RTW Biotech Opportunities's Beta falls into.



RTW Biotech Opportunities Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


RTW Biotech Opportunities  (LSE:RTW) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


RTW Biotech Opportunities Beta Related Terms

Thank you for viewing the detailed overview of RTW Biotech Opportunities's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


RTW Biotech Opportunities Business Description

Traded in Other Exchanges
N/A
Address
St Julian’s Avenue, Royal Chambers, 1st Floor, Saint Peter Port, GGY, GY1 3JX
RTW Biotech Opportunities Ltd is an investment fund focused on identifying transformative assets with growth potential across the life sciences sector. Its approach is driven by applying deep scientific expertise with a long-term investment horizon.

RTW Biotech Opportunities Headlines

No Headlines